TY - JOUR T1 - SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 JF - medRxiv DO - 10.1101/2020.07.17.20155333 SP - 2020.07.17.20155333 AU - Stéphanie Baggio AU - Arnaud G. L’Huillier AU - Sabine Yerly AU - Mathilde Bellon AU - Noémie Wagner AU - Marie Rohr AU - Angela Huttner AU - Géraldine Blanchard-Rohner AU - Natasha Loevy AU - Laurent Kaiser AU - Frédérique Jacquerioz AU - Isabella Eckerle Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/19/2020.07.17.20155333.abstract N2 - The role of children in the transmission of SARS-CoV-2 is unclear. We analysed viral load at the time of diagnosis in 53 children vs. 352 adults with COVID-19 in the first 5 days post symptom onset. No significant differences in SARS-CoV-2 RNA loads were seen between children and adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the Swiss National Foundation (SNF number 31CA30_196732/1, C.A. Siegrist), the Fondation de Bienfaisance du Groupe Pictet and the Fondation privee des HUGAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The work was approved by the Cantonal ethics committee (no. 2020-00813; no. 2020-00835, no. 2020-00516). All study participants and/or their legal guardians provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesna ER -